Marco Giovannini

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Inflammatory Response

Top Venues

Journal of neuro-oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, Marco Giovannini
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of neuro-oncology 167 (2) (2024)
Christine Chiasson-MacKenzie, Jeremie Vitte, Ching-Hui Liu, Emily A Wright, Elizabeth A Flynn, Shannon L Stott, Marco Giovannini, Andrea I McClatchey
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nature communications 14 (1) (2023)
Christine Chiasson-MacKenzie, Jeremie Vitte, Ching-Hui Liu, Emily A Wright, Elizabeth A Flynn, Shannon L Stott, Marco Giovannini, Andrea I McClatchey
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nature communications 14 (1) (2023)
Christine Chiasson-MacKenzie, Jeremie Vitte, Ching-Hui Liu, Emily A Wright, Elizabeth A Flynn, Shannon L Stott, Marco Giovannini, Andrea I McClatchey
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nature communications 14 (1) (2023)
Jeremie Vitte, Fuying Gao, Giovanni Coppola, Alexander R Judkins, Marco Giovannini
Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development. Nature communications 8 (1) (2017)